Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 18;14(4):886.
doi: 10.3390/pharmaceutics14040886.

An Overview of Cell Membrane Perforation and Resealing Mechanisms for Localized Drug Delivery

Affiliations
Review

An Overview of Cell Membrane Perforation and Resealing Mechanisms for Localized Drug Delivery

Stephanie He et al. Pharmaceutics. .

Abstract

Localized and reversible plasma membrane disruption is a promising technique employed for the targeted deposition of exogenous therapeutic compounds for the treatment of disease. Indeed, the plasma membrane represents a significant barrier to successful delivery, and various physical methods using light, sound, and electrical energy have been developed to generate cell membrane perforations to circumvent this issue. To restore homeostasis and preserve viability, localized cellular repair mechanisms are subsequently triggered to initiate a rapid restoration of plasma membrane integrity. Here, we summarize the known emergency membrane repair responses, detailing the salient membrane sealing proteins as well as the underlying cytoskeletal remodeling that follows the physical induction of a localized plasma membrane pore, and we present an overview of potential modulation strategies that may improve targeted drug delivery approaches.

Keywords: cytoskeletal remodeling; endocytosis; exocytosis; membrane permeability; plasma membrane repair; pore; sonoporation; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of known plasma membrane resealing mechanisms. (a) The tension–reduction hypothesis; (b) the patch hypothesis; (c) the ESCRT mechanism; and (d) exocytosis/endocytosis. See text for details.

Similar articles

Cited by

References

    1. Allen T.M., Cullis P.R. Drug delivery systems: Entering the mainstream. Science. 2004;303:1818–1822. doi: 10.1126/science.1095833. - DOI - PubMed
    1. Manzari M.T., Shamay Y., Kiguchi H., Rosen N., Scaltriti M., Heller D.A. Targeted drug delivery strategies for precision medicines. Nat. Rev. Mater. 2021;6:351–370. doi: 10.1038/s41578-020-00269-6. - DOI - PMC - PubMed
    1. Stewart M.P., Langer R., Jensen K.F. Intracellular delivery by membrane disruption: Mechanisms, strategies, and concepts. Chem. Rev. 2018;118:7409–7531. doi: 10.1021/acs.chemrev.7b00678. - DOI - PMC - PubMed
    1. Peer D., Karp J.M., Hong S., FaroKhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007;2:751–760. doi: 10.1038/nnano.2007.387. - DOI - PubMed
    1. Langer R. New Methods of Drug Delivery. Science. 1990;249:1527–1533. doi: 10.1126/science.2218494. - DOI - PubMed

LinkOut - more resources